Age-Related Practice Effects Across Longitudinal Neuropsychological Assessments in Older People With Schizophrenia

Neuropsychology

Volumn 24, Issue 5, 2010, Pages 616-624

  Granholm, Eric ^a   Link, Peter ^b   Fish, Scott ^c   Kraemer, Helena ^d   Jeste, Dilip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Aging; Clinical trials; Cognitive impairment; Practice effects; Schizophrenia

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; FEMALE; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PERFORMANCE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGED; AGING; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEARNING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; NEUROPSYCHOLOGICAL TESTS; PRACTICE (PSYCHOLOGY); PSYCHOTIC DISORDERS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77956543052     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/a0019560     Document Type: Article

References (48)

1. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Author, Washington, DC. 4th ed.
2. Andreasen N.C., Olsen S. Negative v positive schizophrenia. Definition and validation. Archives of General Psychiatry 1982, 39:789-794.
3. Barnett J.H., Croudace T.J., Jaycock S., Blackwell C., Hynes F., Sahakian B.J., Jones P.B. Improvement and decline of cognitive function in schizophrenia over one year: A longitudinal investigation using latent growth modelling. Biomed Central Psychiatry 2007, 7:16.
4. Benton A.L., Hamsher K. Multilingual aphasia exam 1989, AJA Associates, Iowa City, IA.
5. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: Implications for assessment. Schizophrenia Bulletin 2006, 32:238-245.
6. Blyler C.R., Gold J.M. Cognitive effects of typical antipsychotic medication treatment: Another look. Cognition in schizophrenia, impairments, importance and treatment strategies 2000, 241-265. Oxford University Press, Oxford, U.K. T. Sharma, P.D. Harvey (Eds.).
7. Conway G.T., Nicholls S.S., Wexler B.E., Bell M.D. Test-retest stability of neuropsychological testing and individual differences in variability in schizophrenia outpatients. Psychiatry Research 2004, 129:241-247.
8. Delis D.C., Kaplan E., Kramer J.H., Ober B.A. California Verbal Learning Test-II (CVLT-II) Manual 2000, The Psychological Corporation, San Antonio.
9. Dikmen S.S., Heaton R.K., Grant I., Temkin N.R. Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. Journal of the International Neuropsychological Society 1999, 5:346-356.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Inerview for DSM-IV Axis I Disorder-Patient Edition (SCID-I/P). New York Psychiatric Institute 1995.
11. Foster P. Neuroleptic equivalence. Pharmacology 1989, 290:431-432.
12. Friedman J.I., Harvey P.D., Coleman T., Moriarty P.J., Bowie C., Parrella M., Davis K.L. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer's disease and normal aging. American Journal of Psychiatry 2001, 158:1441-1448.
13. Fucetola R., Seidman L.J., Kremen W.S., Faraone S.V., Goldstein J.M., Tsuang M.T. Age and neuropsychologic function in schizophrenia: A decline in executive abilities beyond that observed in healthy volunteers. Biological Psychiatry 2000, 15:137-146.
14. Gibbons R.D., Hedecker D., Elkin I.E., Waternaux C., Kraemer H.C., Greenhouse J.B., Watkins J.T. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Archives of General Psychiatry 1993, 50:739-750.
15. Goldberg T.E., Goldman R.S., Burdick K.E., Malhotra A.K., Lencz T., Patel R.C., Robinson D.G. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: Is it a practice effect?. Archives of General Psychiatry 2007, 64:1115-1122.
16. Goldberg T.E., Weinberger D.R., Berman K.F., Pliskin N.H., Podd M.H. Further evidence for dementia of the prefontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Archives of General Psychiatry 1987, 44:1008-1014.
17. Golden C.J. Stroop Color and Word Test 1978, Stoelting Company, Chicago.
18. Grube B.S., Bilder R.M., Goldman R.S. Meta-analysis of symptom factors in schizophrenia. Schizophrenia Research 1998, 31:113-120.
19. Harvey P.D., Bertisch H., Friedman J.I., Marcus S., Parrella M., White L., Davis K.L. The course of functional decline in geriatric patients with schizophrenia: Cognitive-functional and clinical symptoms as determinants of change. American Journal of Geriatric Psychiatry 2003, 11:610-619.
20. Harvey P.D., Palmer B.W., Heaton R.K., Mohamed S., Kennedy J., Brickman A. Stability of cognitive performance in older patients with schizophrenia: An 8-week test-retest study. American Journal of Psychiatry 2005, 162:110-117.
21. Harvey P.D., Silverman J.M., Mohs R.C., Parrella M., White L., Powchik P., Davis K.L. Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry 1999, 45:32-40.
22. Harvey P.D., White L., Parrella M., Putnam K.M., Kincaid M.M., Powchik P., Davidson M. The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. British Journal of Psychiatry 1995, 166:630-633.
23. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test manual- revised and expanded 1993, Odessa, Fla.
24. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 2001, 58:24-32.
25. Heaton R.K., Temkin N., Dikmen S., Avitable N., Taylor M.J., Marcotte T.D., Grant I. Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Archives of Clinical Neuropsychology 2001, 16:75-91.
26. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
27. Jacobson N.S., Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
28. Jeste D.V., Wyatt R. Understanding and treating tardive dyskinesia 1982, Guilford Press Inc, New York.
29. Keefe R.S., Malhotra A.K., Meltzer H.Y., Kane J.M., Buchanan R.W., Murthy A., Goldman R. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: Significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 2008, 33:1217-1228.
30. Kurtz M.M. Neurocognitive impairment across the lifespan in schizophrenia: An update. Schizophrenia Research 2005, 74:15-26.
31. Laenen A., Vangeneugden T., Geys H., Molenberghs G. Generalized reliability estimation using repeated measurements. British Journal of Mathematical and Statistical Psychology 2006, 59:113-131.
32. McCaffrey R.J., Duff K. Practitioner's guide to evaluating change with neuropsychological assessment instruments 2000, Springer, New York.
33. Mishara A.L., Goldberg T.E. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book. Biological Psychiatry 2004, 55:1013-1022.
34. Nayak S.G., Moore D.J., Roesch S.C., Heaton R.K., Jeste D.V., Palmer B.W. An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: Use of mixed-model analyses. Schizophrenia Research 2006, 83:215-223.
35. Nuechterlein K.H., Green M. Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) 2002, Harcourt, New York.
36. Palmer B.W., Heaton R.K., Paulsen J.S., Kuck J., Braff D., Harris M.J., Jeste D.V. Is it possible to be schizophrenic yet neuropsychologically normal?. Neuropsychology 1997, 11:437-446.
37. Paulsen J.S., Heaton R.K., Sadek J.R., Perry W., Delis D.C., Braff D., Jeste D.V. The nature of learning and memory impairments in schizophrenia. Journal of the International Neuropsychological Society 1995, 1:88-99.
38. Peralta V., Cuesta M.J. Dimensional structure of psychotic symptoms: An item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophrenia Research 1999, 38:13-26.
39. Raudenbush S.W., Bryk A.S., Cheong Y.F., Congdon R.T. HLM v6.02 hierarchical linear and nonlinear modeling 2001, Scientific Software International, Inc, Lincolnwood.
40. Reitan R.M., Wolfson D. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation 1993, Neuropsychology Press, Tucson, AZ. 2 Ed.
41. Rosmark B., Osby U., Engelbrektson K., Nyman H. Stability of performance on neuropsychological tests in patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 1999, 249:299-304.
42. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychological Assessment 1996, 8:269-289.
43. Serper M.R., Bergman R.L., Harvey P.D. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Research 1990, 32:281-288.
44. Shieh Y., Fouladi R.T. The effect of multicollinearity on multilevel modeling parameter estimates and standard errors. Educational and Psychological Measurement 2003, 63:951-985.
45. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: Meta-analysis. British Journal of Psychiatry 2008, 192:248-257.
46. Temkin N.R., Heaton R.K., Grant I., Dikmen S.S. Detecting significant change in neuropsychological test performance: A comparison of four models. Journal of the International Neuropsychological Society 1999, 5:357-369.
47. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale. Administration and scoring manual 1997, The Psychological Corporation/Harcourt Brace, San Antonio. 3rd ed.
48. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: Dose effects and comparison to practice effects. Schizophrenia Research 2007, 89:211-224.